Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 16, 2026

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
05:30

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Published on: February 14, 2025

Long-term complication after LM bifurcation treatment.

Marco V Wainstein1, Jorge P Ribeiro

  • 1Cardiology Division, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil. mvwainstein@uol.com.br

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|February 11, 2010
PubMed
Summary

A simplified "L" technique using two bioabsorbable stents effectively treated severe coronary artery restenosis in the left main (LM) and left circumflex (LCx) arteries, avoiding the left anterior descending (LAD) artery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

P2Y12 inhibitor monotherapy versus dual antiplatelet therapy after complex percutaneous coronary intervention in patients with acute coronary syndromes: a NEO-MINDSET trial substudy.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Right Ventricular ST-Segment Elevation Myocardial Infarction and Pulmonary Congestion: Insights From a Prospective Cohort of Patients Evaluated by Admission Lung Ultrasound.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2025
Same author

Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes.

The New England journal of medicine·2025
Same author

Letter regarding the article 'Lung ultrasound and mortality in a cardiogenic shock population: A prospective registry-based analysis'.

European journal of heart failure·2025
Same author

Registry of Percutaneous Closure of Patent Foramen Ovale in the Secondary Prevention of Stroke.

Arquivos brasileiros de cardiologia·2024
Same author

Real-World Assessment of an Ultrathin Strut, Sirolimus-Eluting Stent in Patients with ST-Elevation Myocardial Infarction Submitted to Primary Percutaneous Coronary Intervention (INSTEMI Registry).

Arquivos brasileiros de cardiologia·2023

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Biomaterials Science

Background:

  • Bare metal stent implantation in the left anterior descending (LAD) and left circumflex (LCx) arteries can lead to restenosis.
  • In-stent restenosis, particularly with left main (LM) coronary involvement, presents a complex interventional challenge.

Observation:

  • A patient developed subocclusive in-stent restenosis in the LCx coronary artery with severe LM involvement two months post-stenting.
  • The left anterior descending (LAD) artery was previously stented.

Findings:

  • A simplified "L" technique was employed for unprotected LM percutaneous coronary intervention.
  • Two bioabsorbable biolimus-eluting stents were successfully deployed without involving the LAD coronary artery.

Related Experiment Videos

Last Updated: Jun 16, 2026

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
05:30

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Published on: February 14, 2025

Implications:

  • This simplified "L" technique offers a viable strategy for managing complex LM coronary interventions.
  • The use of bioabsorbable stents in this context highlights advancements in drug-eluting stent technology.
  • This approach may reduce procedural complexity and improve outcomes in patients with unprotected LM disease.